Home/Filings/4/0000914190-18-000134
4//SEC Filing

MCNAY JOSEPH C 4

Accession 0000914190-18-000134

CIK 0000707511other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:37 PM ET

Size

7.1 KB

Accession

0000914190-18-000134

Insider Transaction Report

Form 4
Period: 2018-03-29
Transactions
  • Conversion

    Common Stock

    2018-03-29$0.06/sh+1,044,560$62,6742,868,162 total
  • Conversion

    Convertible Promissory Note (right to buy)

    2018-03-291,044,5600 total
    Exercise: $0.06From: 2013-03-29Exp: 2018-03-29Common Stock (1,044,560 underlying)
Footnotes (1)
  • [F1]The Convertible Promissory Note in the principal amount of $50,000 accrued $12,673.60 in interest and both principal and interest were converted into 1,044,560 shares of common stock at a conversion price of $0.06 per share.

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

Entity typeother

Related Parties

1
  • filerCIK 0001257674

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:37 PM ET
Size
7.1 KB